Status:
COMPLETED
Effect of Rapid Transfusion With Fluid Management System 2000® (FMS)
Lead Sponsor:
Seoul National University Hospital
Conditions:
Liver Transplantation
Eligibility:
All Genders
16-80 years
Phase:
NA
Brief Summary
Rapid infusion of red blood cells is known to result in the increase of plasma potassium. The researchers are trying to investigate the change in plasma potassium during rapid infusion of mixed blood ...
Detailed Description
FMS is a standard equipment to prepare for the massive bleeding during the liver transplant surgery. This device usually delivers a mixture of red blood cell (RBC), fresh frozen plasma and normal sali...
Eligibility Criteria
Inclusion
- liver transplantation recipients
Exclusion
- hemoglobin \> 10 g/dL before surgery
- renal failure
- hyperkalemia
- chronic hyponatremia
- cardiac dysfunction
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01448343
Start Date
October 1 2011
End Date
March 1 2012
Last Update
April 16 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 110-799